Subscribe To
KPRX / Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference
KPRX News
By Newsfile Corp
October 16, 2023
Kiora Pharmaceuticals to Participate in the Lytham Partners Fall 2023 Investor Conference
Encinitas, California--(Newsfile Corp. - October 16, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online prese more_horizontal
By Newsfile Corp
September 14, 2023
Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa
Encinitas, California--(Newsfile Corp. - September 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that r more_horizontal
By InvestorPlace
August 23, 2023
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 11% Today?
Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is getting a boost on Wednesday after the company revealed new patents in the U.S. and Europe. According t more_horizontal
By InvestorPlace
July 21, 2023
Why Is Kiora Pharmaceuticals (KPRX) Stock Down 7% Today?
Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is dropping on Friday after the clinical-stage pharmaceutical company received a delisting notice. That d more_horizontal
By InvestorPlace
June 2, 2023
Why Is Kiora Pharmaceuticals (KPRX) Stock Down 49% Today?
Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is falling hard on Friday after the company revealed details of a public share offering. The offering has more_horizontal
By Pulse2
February 8, 2023
KPRX Stock: 38.7% Surge Explanation
The stock price of Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) surged by 38.7% in the most recent trading session. This is why. more_horizontal
By InvestorPlace
February 7, 2023
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 61% Today?
Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is heading higher on Tuesday thanks to an update on its KIO-101 eye drops. The big news here is the treatm more_horizontal
By Newsfile Corp
February 8, 2022
Kiora Pharmaceuticals Announces Participation at 2022 BIO CEO & Investor Conference
Salt Lake City, Utah--(Newsfile Corp. - February 8, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced today tha more_horizontal